<DOC>
	<DOCNO>NCT02447822</DOCNO>
	<brief_summary>This prospective randomized control study evaluate feasibility safety early steroid withdrawal 6mg/kg v 4.5mg/kg Thymoglobulin induction therapy kidney transplantation . Patients enrol June , 2015 24 month . They randomize either 6mg/kg 4.5mg/kg Thymoglobulin induction group . Steroid withdrawal do within one week kidney transplantation patient . Maintenance immunosuppressant Tacrolimus Mycophenolate mofetil ( Myfortic ) . Primary outcome composite biopsy-proven acute rejection , delay graft function , graft loss death within one year post transplant .</brief_summary>
	<brief_title>Thymoglobulin Induction Therapy Kidney Transplantation ( 6mg/kg vs 4mg/kg )</brief_title>
	<detailed_description />
	<mesh_term>Renal Insufficiency</mesh_term>
	<criteria>Male female patient renal failure 18 70 year age Candidates cadaveric live donor kidney transplantation Patients able willing consent protocol study Patients receive immunosuppressive therapy transplantation Patients receive investigational medication within past 30 day Patients known contraindication administration antithymocyte globulin Patients suspect known infection seropositive hepatitis B surface antigen ( HBsAg ) , antibody hepatitis B core antigen ( antiHBcAg ) , hepatitis C virus ( HCV ) , human immunodeficiency virus ( HIV ) Patients cancer ( except non melanoma skin cancer ) within previous 2 year Pregnant woman , nurse mother , woman childbearing potential use condoms oral contraceptive</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>May 2015</verification_date>
</DOC>